Mark W Johnson

Mark W Johnson, MD, FACS


Business Phone: (352) 265-0606

About Mark W Johnson

In just sixth grade, I knew I would be Dr. Johnson. Since that’s come to fruition, I have been recognized by the renowned Best Doctors in America publication and have received the Montague Boyd Award twice, which is given annually to recognize the achievements of academic scholarships and contributions to medical practice and knowledge. In my 25 plus years of practice, I found inspiration in transplant, for the ability to give patients the gift of life.

As a professor of surgery in the division of transplantation surgery, I treat patients at the end stage of liver and kidney disease, diabetes with kidney disease and pancreas, and biliary disease. My clinical interests include liver transplantation, renal transplantation and surgical management of hepato-biliary diseases.

Prior to joining the University of Florida College of Medicine, I worked as chief transplant officer and medical director of transplant services at Wellstar Health System in Marietta, Georgia, as chairman and program director of the Piedmont Transplant Institute in Atlanta and as director of both kidney and liver transplant services at the University of North Carolina in Chapel Hill.

I earned my medical degree from Tufts University School of Medicine and completed a general residency at New England Medical Center in Boston. Afterwards, I completed a clinical and research fellowship in transplantation surgery at Harvard Medical School.

In my free time, I enjoy many outdoor activities, including mountain biking, pickle ball and relaxing at the beach with my kids.

Teaching Profile

Courses Taught
MDC7600 Surgery Clerkship

Board Certifications

  • Surgery
    American Board of Surgery

Clinical Profile

  • Transplant Surgery
  • Transplant Surgery
Areas of Interest
  • End-stage kidney disease
  • Kidney Transplant
  • Liver disease
  • Pancreas Transplant
  • Renal


Locoregional Therapy Protocols With and Without Radioembolization for Hepatocellular Carcinoma as Bridge to Liver Transplantation
American Journal of Clinical Oncology-Cancer Clinical Trials. 43(5):325-333 [DOI] 10.1097/COC.0000000000000678. [PMID] 32079854.
Multivariate analysis of prognostic factors for survival following doxorubicin-eluting bead transarterial chemoembolization for hepatocellular carcinoma.
Journal of vascular and interventional radiology : JVIR. 24(5):647-54 [DOI] 10.1016/j.jvir.2012.12.003. [PMID] 23384831.
Use of transjugular intrahepatic portosystemic shunt as a bridge to liver transplantation in a patient with severe hepatopulmonary syndrome.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 7(2):147-9 [PMID] 11172400.


Fellowship – Abdominal Transplantation
1995 · Massachusetts General Hospital
Residency – Surgery
1993 · Tufts University
Internship – Surgery
1989 · Tufts University
Medical Degree
1988 · Tufts University

Contact Details

(352) 265-0606
Business Mailing:
PO Box 100118
Business Street:
1600 SW Archer Rd, Rm 6142